Zealand Pharma’s petrelintide delivers double-digit weight loss in next-gen obesity treatment

The double-blind, dose-finding ZUPREME-1 trial enrolled 485 adults with overweight or obesity

LabGenius and LG Chem strike AI-powered deal to develop next-gen tumour-targeting antibody therapy

The collaboration is focused on overcoming a major limitation in existing cancer drugs

Automated cell therapy manufacturing attracts US$1.1 Billion across 34 funding rounds

New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones

Sameer Garaye promoted to Vice President at Hetero

Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities

Cancer treatment must move beyond one-size-fits-all decisions: Dr. Manjiri Bakre, CEO and Founder, OncoStem Diagnostics

One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally

Suven reports positive Phase 2b results for Ropanicant in major depressive disorder

Suven has already begun planning a global Phase 3 registrational program for MDD based on the results

Brinton Pharma appoints Sathya Narayanan as CEO – India and JPAC

Industry veteran with over two decades of experience to lead expansion across India, South Asia, Southeast Asia, and other high-growth healthcare markets

Indian pharma market logs sixth straight month of double-digit growth in May

Market grows 12.1%; volume contribution improves as 9 out of 10 key therapies post double-digit growth

Mabion reactivates MabionCD20 through rare disease collaboration with Oddifact

MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies

Orionis expands Novartis partnership in potential $1.4 billion molecular glue drug feal